Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

5.9K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.9K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

7.3K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.3K
Structure and Function of Platelets01:18

Structure and Function of Platelets

1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

686
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Monovalent antibody treatment of von Willebrand disease.

Blood advances·2026
Same author

Decoration of gold nanoparticles with glycopeptides leads to a lower cellular uptake and liver retention.

Nanoscale advances·2025
Same author

Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program.

Blood advances·2025
Same author

Clinical phenotype and pathophysiological mechanisms underlying qualitative low VWF.

Blood·2025
Same author

Enhanced α2-3-linked sialylation determines the extended half-life of CHO-rVWF.

Blood·2025
Same author

Patient-reported data on the severity of Von Willebrand disease.

Haemophilia : the official journal of the World Federation of Hemophilia·2024

Related Experiment Video

Updated: Jun 26, 2025

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.2K

Novel functions for von Willebrand factor.

Ferdows Atiq1, James S O'Donnell1,2

  • 1Irish Centre for Vascular Biology, School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland.

Blood
|May 10, 2024
PubMed
Summary

Von Willebrand factor (VWF) interacts with over 60 ligands, influencing hemostasis and non-hemostatic functions like inflammation and wound healing. These interactions are key to understanding various diseases beyond bleeding disorders.

More Related Videos

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

11.6K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

10.7K

Related Experiment Videos

Last Updated: Jun 26, 2025

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
08:30

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation

Published on: August 14, 2017

11.2K
Live-cell Imaging of Platelet Degranulation and Secretion Under Flow
11:42

Live-cell Imaging of Platelet Degranulation and Secretion Under Flow

Published on: July 10, 2017

11.6K
In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions
10:24

In Vitro and In Vivo Model to Study Bacterial Adhesion to the Vessel Wall Under Flow Conditions

Published on: June 11, 2015

10.7K

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pathophysiology

Background:

  • Von Willebrand factor (VWF) is crucial for normal hemostasis, known to interact with factor VIII, collagen, and platelets.
  • Recent research reveals VWF interacts with over 60 novel ligands, with specific domains implicated in these interactions.

Purpose of the Study:

  • To review novel ligand interactions of VWF.
  • To assess the impact of these interactions on VWF biology and cellular functions.
  • To explore the role of non-hemostatic VWF functions in human diseases.

Main Methods:

  • Literature review of accumulating data on VWF interactions.
  • Critical assessment of studies on VWF-ligand binding and functional consequences.
  • Analysis of evidence linking non-hemostatic VWF functions to disease pathogenesis.

Main Results:

  • Over 60 VWF-binding partners identified, some with domain-specific interactions.
  • Novel ligands regulate VWF biosynthesis, proteolysis, and clearance.
  • VWF binding affects the functional properties of some ligands.
  • Emerging roles for VWF in inflammation, wound healing, angiogenesis, and bone metabolism.

Conclusions:

  • VWF's interactions extend beyond hemostasis, impacting diverse cellular processes.
  • Non-hemostatic VWF functions contribute to the pathogenesis of diseases such as sepsis, malaria, sickle cell disease, and liver disease.
  • Understanding these novel interactions is vital for comprehending VWF's multifaceted roles in health and disease.